Director at ICU Medical (ICUI) gains 1,475 RSUs and 1,254 shares

Rhea-AI Filing Summary

ICU Medical director David F. Hoffmeister reported compensation-related equity activity. On May 13, 2026, he acquired 1,254 shares of Common Stock through the exercise of previously granted Restricted Stock Units, bringing his direct holdings to 6,004 shares of Common Stock.

On the same date, he also received a new award of 1,475 Restricted Stock Units. These RSUs have no purchase or exercise price and are scheduled to vest on the anniversary of the grant date or at the following annual stockholder meeting, whichever occurs first. The filing shows no open-market purchases or sales.

Insider Trade Summary

1,254 shares exercised/converted

Mixed 3 txns

Insider Hoffmeister David F

Role null

Type	Security	Shares	Price	Value
Exercise	Common Stock	1,254	$0.00	--
Grant/Award	Common Stock	1,475	$0.00	--
Exercise	Common Stock	1,254	$0.00	--

Holdings After Transaction: Common Stock — 0 shares (Direct, null)

Footnotes (1)

1. These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units. These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

Key Figures

RSU shares exercised: 1,254 shares Shares held after exercise: 6,004 shares New RSU grant size: 1,475 RSUs +2 more

5 metrics

RSU shares exercised 1,254 shares Common Stock acquired via RSU exercise on May 13, 2026

Shares held after exercise 6,004 shares Direct Common Stock holdings following RSU conversion

New RSU grant size 1,475 RSUs Restricted Stock Units granted May 13, 2026

RSU exercise price $0.00 per unit No purchase or exercise price for Restricted Stock Units

RSU vesting/expiration date May 13, 2027 Grant and expiration date for 1,475 RSUs

Key Terms

Restricted Stock Units, exercise or conversion of derivative security, grant, award, or other acquisition, annual stockholder meeting

4 terms

Restricted Stock Units financial

"These securities are Restricted Stock Units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

annual stockholder meeting financial

"vest on the anniversary of the date of the grant or the following annual stockholder meeting"

An annual stockholder meeting is a yearly gathering where a company's owners (shareholders) receive updates on performance, vote on key issues like board members, executive pay and major corporate plans, and ask questions of management. Think of it as a company town hall where choices about oversight and direction are decided; outcomes can affect management accountability, corporate strategy and ultimately the value and risks of investors’ shares.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoffmeister David F

(Last) (First) (Middle)

951 CALLE AMANECER

(Street)

SAN CLEMENTE CALIFORNIA 92673

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	05/13/2026		M		1,254	A	$0.0	6,004	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock(1)	$0.0(2)	05/13/2026		M			1,254	05/13/2026(3)	05/13/2026	Common Stock	1,254	$0.0	0	D
Common Stock(1)	$0.0(2)	05/13/2026		A		1,475		05/13/2027(3)	05/13/2027	Common Stock	1,475	$0.0	1,475	D

Explanation of Responses:

1. These securities are Restricted Stock Units.

2. There is neither a purchase price nor an exercise price for the Restricted Stock Units.

3. These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

	By: Paula Darbyshire, Attorney-in-Fact For: David F. Hoffmeister	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did ICU Medical (ICUI) director David F. Hoffmeister report?

He reported acquiring 1,254 ICU Medical common shares via Restricted Stock Unit vesting and receiving a new grant of 1,475 RSUs. These transactions are compensation-related equity awards, not open-market stock purchases or sales, and increase his overall exposure to ICU Medical stock.

How many ICU Medical (ICUI) shares does David F. Hoffmeister hold after this Form 4?

After the reported RSU exercise, he directly holds 6,004 shares of ICU Medical common stock. This figure reflects his position following the 1,254-share RSU conversion on May 13, 2026, and does not include the newly granted 1,475 unvested Restricted Stock Units.

What is the size of the new RSU grant to the ICU Medical (ICUI) director?

He received a grant of 1,475 Restricted Stock Units tied to ICU Medical common stock. These RSUs carry no purchase or exercise price and represent a stock-based compensation award that will convert into shares once they vest under the award’s stated schedule.

When do the newly granted ICU Medical (ICUI) RSUs vest for the director?

The RSUs vest on the anniversary of the grant date or at the following annual stockholder meeting, whichever occurs first. This schedule means vesting is tied to the company’s governance calendar rather than performance targets or multi-year service conditions.

Is there any exercise price for the ICU Medical (ICUI) Restricted Stock Units reported?

The filing states there is neither a purchase price nor an exercise price for the Restricted Stock Units. When they vest, they convert into ICU Medical common shares without the director paying cash, functioning as share-based compensation rather than traditional stock options.

Does this ICU Medical (ICUI) Form 4 show any open-market stock sales or purchases?

No, the transactions are an RSU-based share acquisition and a new RSU grant, both at a stated price of $0.00 per unit. The report shows no open-market buying or selling activity, only compensation-related equity movements for the director on May 13, 2026.